Research and Markets (http://www.researchandmarkets.com/research/039aba/portal_hypertensio) has announced the addition of new report "Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019" to their offering.

The Portal Hypertension Therapeutics Market is Forecast to Show Slow Growth

The global portal hypertension therapeutics market is estimated to be valued at $1.7 billion in 2011. It is expected to grow to $1.9 billion at a Compound Annual Growth Rate (CAGR) of 2.0% by 2019. This slow growth is due to the slow increase in the prevalent population, the domination of the market by generics and low likelihood of new product launches during the forecast period.

Current Treatment Options Create Significant Unmet Need in the Market

GlobalData's analysis found that the unmet need in the portal hypertension market is significant, which implies that the market is not well served by the current treatment options. There are no drugs approved for the treatment of portal hypertension. The market is dominated by off-label generic drugs. Beta-blockers are the drugs mainly used for treatment of portal hypertension. However, due to contraindications and side effects beta-blocker therapy is discontinued in many patients. Therefore there is a need for novel drugs with better safety and efficacy profiles to capture the untapped market.

This report is an essential source of information and analysis on the global Portal Hypertension Therapeutics market. The report identifies the key trends shaping and driving the global Portal Hypertension Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Portal Hypertension Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Key Topics Covered:

  • Portal Hypertension Cirrhosis Therapeutics - Introduction
  • Portal Hypertension Therapeutics - Market Characterization
  • Portal Hypertension Therapeutics - Competitive Assessment
  • Portal Hypertension Therapeutics - Pipeline Assessment
  • Portal Hypertension Therapeutics - Clinical Trials Mapping
  • Portal Hypertension Therapeutics - Strategic Assessment
  • Portal Hypertension Therapeutics - Future Players

Companies Mentioned:

  • Chiasma (Israel) Ltd.
  • Dong-A Pharmaceutical Co Ltd (Dong-A)

For more information visit http://www.researchandmarkets.com/research/039aba/portal_hypertensio